Theranica is a health-tech startup that operates in the digital therapeutics market, specifically focusing on pain management. The company's primary product, Nerivio, is a wearable device that uses remote electrical neuromodulation (REN) to manage pain. REN is a method of pain management that involves stimulating peripheral nerves in the upper arm to trigger a natural pain relief mechanism in the body known as Conditioned Pain Modulation (CPM). This is based on the idea that in certain diseases, such as migraines, the brain misinterprets harmless stimuli as painful. By triggering CPM, the device can increase the release of certain neurotransmitters in the brain stem that can effectively shut down the pain.

Theranica's business model revolves around the prescription of its digital therapeutics. This means that their primary clients are healthcare providers who prescribe the Nerivio device to their patients suffering from conditions like migraines. The company makes money by selling these devices to healthcare providers or directly to patients with a prescription.

In terms of market, Theranica operates in the rapidly growing digital therapeutics sector, which is part of the broader healthcare technology industry. This market is driven by the increasing prevalence of chronic diseases and the growing need for effective, non-invasive pain management solutions.

Keywords: Theranica, Digital Therapeutics, Pain Management, Prescription, Healthcare Technology, Nerivio, Remote Electrical Neuromodulation, Conditioned Pain Modulation, Wearable Device, Migraine.